JULIE AULL: Open Payments
NPI 1982617387 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$683 in 34 payments from 12 companies in 2025. Trend: 2023 $913 · 2024 $1,524 · 2025 $683
Food & beverage: $683
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $318 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| PFIZER INC. | 2 | $35 |
| Novo Nordisk Inc | 2 | $35 |
| Exact Sciences Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $19 |
| Boston Scientific Corporation | 1 | $19 |
Products named: VRAYLAR, QULIPTA, VOQUEZNA, UBRELVY, Kerendia, TRINTELLIX, PREVNAR 20, Ozempic.
Industry payments across IN — which companies pay providers there.
